PeptideAA Water
0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.

Modified C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Lyophilized.
In Stock
AOD9604 is a synthetic peptide corresponding to a modified C-terminal fragment of human growth hormone (residues 177-191) with an added tyrosine residue at the N-terminus.
The fragment has been studied in preclinical literature for its activity in lipid-metabolism research models, independently of the broader growth-hormone signalling pathway.
Supplied as a sterile lyophilized powder under inert atmosphere. Reconstitute with sterile bacteriostatic water and store reconstituted samples at 2-8 °C. For laboratory and research use only. Not for human or veterinary use.
Every batch of AOD9604 is independently tested by a third-party laboratory. Certificates of Analysis include HPLC purity testing, mass spectrometry confirmation, and sterility verification.
Contact us at info@spartalabs.net to request the COA for this product.
Orders are processed within 1–2 business days. Standard shipping typically takes 3–5 business days within the continental United States.
All products are shipped in temperature-controlled, discreet packaging to ensure product integrity.
AOD9604 is a synthetic peptide corresponding to a modified C-terminal fragment of human growth hormone (residues 177-191) with an added tyrosine residue at the N-terminus.
The fragment has been studied in preclinical literature for its activity in lipid-metabolism research models, independently of the broader growth-hormone signalling pathway.
Supplied as a sterile lyophilized powder under inert atmosphere. Reconstitute with sterile bacteriostatic water and store reconstituted samples at 2-8 °C. For laboratory and research use only. Not for human or veterinary use.
Peptide0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.
PeptideBacteriostatic Water for Research. Sterile. 10ml vial.
PeptideTetra-substituted GHRH analogue with Drug Affinity Complex. Lyophilized.
PeptideCo-lyophilized 10 mg BPC-157 / 10 mg TB-500. ≥ 99% purity.
PeptideFour-peptide blend: GHK-Cu, TB-500, BPC-157, KPV. 80 mg total. Lyophilized.
PeptideCo-lyophilized 5 mg BPC-157 / 5 mg TB-500. ≥ 99% purity.
PeptideSynthetic hexapeptide ghrelin-receptor agonist. Lyophilized.
PeptideSynthetic tetrapeptide (Ala-Glu-Asp-Gly). Lyophilized.
PeptideSynthetic pentadecapeptide. Lyophilized. ≥ 99% purity.
PeptideLong-acting amylin analogue. Lyophilized. ≥ 99% purity.
PeptideTetra-substituted GHRH (1-29) analogue, no DAC. Lyophilized. ≥ 99% purity.
No reviews yet. Be the first verified buyer to share your experience from your account → orders page after your shipment arrives.
Reviews are open to verified buyers from your account → orders page. Every submission is moderated for compliance — we filter human-use and medical claims evenhandedly across positive and negative reviews. See our review moderation policy for the exact rules and 1–2 business-day review window.
How SpartaLabs sources, tests, and verifies AOD9604 for research applications. Educational reference.
An educational reference summarizing peer-reviewed research on AOD9604, from foundational in vitro biochemistry through six randomized human clinical trials and the subsequent GRAS safety determination.
An educational reference covering the chemistry, pharmacological classification, regulatory status, and discovery history of AOD9604, a synthetic hGH C-terminal fragment with an established safety profile.
An educational reference examining the reported molecular interactions and signaling pathways of AOD9604, a synthetic hGH C-terminal peptide fragment, as described in published preclinical literature.
An educational reference tracing the discovery, pharmaceutical development, clinical trial history, and regulatory milestones of AOD9604 from its origins at Monash University through its FDA GRAS determination.